Literature DB >> 9192664

The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.

P J Lehner1, J T Karttunen, G W Wilkinson, P Cresswell.   

Abstract

In its attempt to evade cytotoxic T cell recognition, human cytomegalovirus encodes several genes that target MHC class I molecules at different points in their assembly pathway. We show here that the human cytomegalovirus US6 gene encodes a 22-kDa glycoprotein that binds the transporter-associated with antigen processing (TAP)/class I complex and inhibits translocation of peptide from the cytosol to the endoplasmic reticulum. Major histocompatibility complex class I molecules are therefore unable to load TAP-dependent peptides, resulting in the retention of MHC class I molecules in the endoplasmic reticulum, with a consequent reduction in class I at the cell surface. Interferon-gamma treatment of US6 transfected cells overcomes this inhibition of peptide translocation and restores class I at the cell surface to wild type levels. The functional consequence of TAP inhibition is that US6 transfected cells are unable to present endogenous antigen to cytotoxic T lymphocytes and are therefore resistant to cytotoxic T lymphocyte lysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192664      PMCID: PMC21257          DOI: 10.1073/pnas.94.13.6904

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.

Authors:  E J Wiertz; D Tortorella; M Bogyo; J Yu; W Mothes; T R Jones; T A Rapoport; H L Ploegh
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

3.  Presentation of viral antigen controlled by a gene in the major histocompatibility complex.

Authors:  V Cerundolo; J Alexander; K Anderson; C Lamb; P Cresswell; A McMichael; F Gotch; A Townsend
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

4.  An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens.

Authors:  H G Burgert; S Kvist
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

7.  Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome.

Authors:  J D Oram; R G Downing; A Akrigg; A A Dollery; C J Duggleby; G W Wilkinson; P J Greenaway
Journal:  J Gen Virol       Date:  1982-03       Impact factor: 3.891

8.  An epitope common to HLA class I and class II antigens, Ig light chains, and beta 2-microglobulin.

Authors:  P M Lutz; P Cresswell
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

9.  Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors.

Authors:  R K Tiwari; J Kusari; G C Sen
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

Authors:  L K Borysiewicz; J K Hickling; S Graham; J Sinclair; M P Cranage; G L Smith; J G Sissons
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  92 in total

1.  A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Authors:  U Reusch; W Muranyi; P Lucin; H G Burgert; H Hengel; U H Koszinowski
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation.

Authors:  Eric W Hewitt; Lidia Duncan; Dina Mufti; John Baker; Philip G Stevenson; Paul J Lehner
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

4.  MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.

Authors:  C Benz; H Hengel
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

5.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens.

Authors:  Anne L Ackerman; Christoph Kyritsis; Robert Tampé; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-15       Impact factor: 11.205

Review 6.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 7.  Virus subversion of protective immunity.

Authors:  Eric W Hewitt; Gillian E Dugan
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 8.  ABC proteins in antigen translocation and viral inhibition.

Authors:  David Parcej; Robert Tampé
Journal:  Nat Chem Biol       Date:  2010-08       Impact factor: 15.040

Review 9.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 10.  Applications of major histocompatibility complex class I molecules expressed as single chains.

Authors:  Tina Primeau; Nancy B Myers; Y Y Lawrence Yu; Lonnie Lybarger; Xiaoli Wang; Steven M Truscott; Ted H Hansen; Janet M Connolly
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.